News - Gensco Pharma

The Only FDA-Approved Prescription Hydrogel and 4% Lidocaine HCl for Debridement and Wound Pain Management

Astero® provides fast relief for painful wounds as fast as 3-5 minutes. Available by prescription only, Astero® is indicated for the relief of painful wounds and wound healing such as ulcerations, pressure wounds, first and second degree burns, post-surgical...

A Case Study of Treatment of Recalcitrant Nonpressure Chronic Ulcers Using Astero Gel Topical Hydrogel with 4% Lidocaine for Autolytic Debridement and Pain Management

A new safe, easy-to-use product heals the ulcer while easing the pain. By Mary Elizabeth Hanley, D.O., UHM Background Chronic wounds are defined as wounds that do not heal within 4 weeks. The Wound Healing Society classifies these wounds into 4 categories: pressure...

An Exploratory, Single-blind Study to Evaluate Both the Onset of Anesthesia of LiDORx® in Patients Aged 18–88 Years

By Patrick Hardigan, BS, MS, PhD, Nova Southeastern University, Director of Clinical Research Background Fear of pain is one reason a patient may be apprehensive about a medical procedure. The most common form of pain control, namely local anesthesia, can itself...

Now Available Through Federal Supply Schedule (FSS)

Contract #V797D-70219 The Only FDA-Approved Prescription Hydrogel and 4% Lidocaine HCl for Pain Associated with Wound Healing and Vasculitis FDA Approved #K092086 Astero®, manufactured by Gensco Pharma, is now available through the Federal Supply Schedule. Astero®...

How to Best Navigate the Specialty Pharmacy Marketplace

Carlos Alfaras, President and CEO of Gensco Pharma, joins Suzette DiMascio, CHE, CMCE, CPC, host of the Specialty Pharmacy Podcast, for an in-depth discussion on how to successfully navigate the specialty pharmacy marketplace and form meaningful partnerships amid...

Physician Explores Gout Treatment Options

As seen in Chain Drug Review | May 15, 2017 MIAMI — Gout is an extremely painful form of inflammatory arthritis and the most common form of this type of arthritis in men, according to Dr. Gary Myerson, a founding fellow of the American College of Rheumatology....

Reduce Patients’ Gout Pain…

…“At the Site” and In Their Pocket Chain Drug Review | April 24, 2017 Gensco Pharma Introduces the First Complete Gout Savings Program The innovative ColciGel® Allopurinol Voucher Program offers patients affordable access to ColciGel® for acute gout flares and...

The Difference Between Topical and Transdermal Medications

White Paper by Robert L. Wilbur, Pharm.D., CPh | Executive Director, Medical Affairs, Gensco Pharma Abstract Topical medications are widely used as prescription or over the counter (OTC) treatments for a variety of conditions. Though, their use is common, there exists...

Working In All Disease States and Cost Management Areas to Help Patients Access Medications

Gensco® President and CEO, Carlos Alfaras, recently moderated a Thought Interaction Pod (TIP) session at the ECRM Specialty Pharmacy EPPS on the topic of “Disease States and Cost Management; The Transitioning of Care in the Changing Healthcare Landscape.”...

Advances in Treatment of Painful Wounds

by Marc Alan Brenner, DPM, The Institute for Diabetic Foot Research As seen in Podiatry Management | November 2016 Wound management is one of the most common aspects of podiatric practice. The etiology of the wound may vary from post-surgical, traumatic, or disease...

LOOKING TO THE FUTURE